Cargando…
Personalized Prediction of Lifetime Benefits with Statin Therapy for Asymptomatic Individuals: A Modeling Study
BACKGROUND: Physicians need to inform asymptomatic individuals about personalized outcomes of statin therapy for primary prevention of cardiovascular disease (CVD). However, current prediction models focus on short-term outcomes and ignore the competing risk of death due to other causes. We aimed to...
Autores principales: | Ferket, Bart S., van Kempen, Bob J. H., Heeringa, Jan, Spronk, Sandra, Fleischmann, Kirsten E., Nijhuis, Rogier L. G., Hofman, Albert, Steyerberg, Ewout W., Hunink, M. G. Myriam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3531501/ https://www.ncbi.nlm.nih.gov/pubmed/23300388 http://dx.doi.org/10.1371/journal.pmed.1001361 |
Ejemplares similares
-
Predictive Value of Updating Framingham Risk Scores with Novel Risk Markers in the U.S. General Population
por: Ferket, Bart S., et al.
Publicado: (2014) -
Validation of a model to investigate the effects of modifying cardiovascular disease (CVD) risk factors on the burden of CVD: the rotterdam ischemic heart disease and stroke computer simulation (RISC) model
por: van Kempen, Bob JH, et al.
Publicado: (2012) -
Sex differences in lifetime risk and first manifestation of cardiovascular disease: prospective population based cohort study
por: Leening, Maarten J G, et al.
Publicado: (2014) -
Prediction of intracranial findings on CT-scans by alternative modelling techniques
por: van der Ploeg, Tjeerd, et al.
Publicado: (2011) -
Iranian general populations' and health care providers' preferences for benefits and harms of statin therapy for primary prevention of cardiovascular disease
por: Saadati, Hassan, et al.
Publicado: (2020)